Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine for AUD and Depression in Youth
NCT05355311Phase 1Completed
- Sponsor
- Brown University
- Start
- Sep 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of levocarnitine in alcohol use disorder (AUD) and major depressive disorder (MDD), sponsored by Brown University. Primary endpoint: Alcohol Craving (Alcohol Urge Questionnaire) at Week 5. Started Sep 2024; status: completed.
02
Drugs
levocarnitine
03
Conditions
alcohol use disorder (AUD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05355311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05355311.